Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Dynavax technologies - The Untold Story

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Dynavax Technologies Earnings Perspective: Return On Capital Employed

Dynavax Technologies Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q4, Dynavax Technologies (NASDAQ:DVAX) earned $99.78 million, a 450.96% increase from the preceding quarter. Dynavax Technologies also posted a total of $195.07 million in sales, a 80.17% increase since Q3.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Recap: Dynavax Technologies Q4 Earnings

Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

A Preview Of Dynavax Technologies's Earnings

Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Dynavax Technologies will report an earnings per share (EPS) of $0.69.

1

Organisations

Core Scientific

Evercore ISI Group

Keurig Dr Pepper

Cincinnati Financial

Arcos Dorados Holdings

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play